Abstract P2067: Loss Of Cardiomyocyte β2 Spectrin Promotes Cardiac Dyad Dysfunction And Accelerated Heart Failure

Abstract

Background: The cardiac dyad is composed of the transverse-tubules, junctional sarcoplasmic reticulum (jSR), and its associated calcium (Ca 2+ ) release units, which are integral for cardiac excitation-contraction (E-C). Proper E-C coupling requires Ca 2+ influx via L-type Ca 2+ channels (LTCC) which triggers Ca 2+ release from adjacent ryanodine receptor 2 (RyR2) receptors located in jSR. Loss of the βII-spectrin scaffolding protein alters RyR2 localization; however, its contribution to cardiac dyad organization and E-C coupling remains unclear. Hypothesis: We hypothesized that βII-spectrin is required for cardiac dyad organization and proper cardiomyocyte calcium signaling. Methods: Cardiomyocyte-specific βII-spectrin knockout (βII-cKO) and control (βII-flox) mice were generated and hearts were harvested for immunoblotting, qRT-PCR, and transmission electron microscopy (TEM). Cardiomyocytes were isolated and stained using proximity ligation assay (PLA) and visualized by confocal microscopy. To assess heart response to pressure overload, control and βII-cKO mice were subjected to transaortic constriction surgery followed by treatment with or without, diltiazem and monitored by echocardiography, and electrocardiography. Results: Cardiac dyad structure and components are significantly altered in βII-cKO hearts. Ultrastructural analysis of βII-cKO hearts showed fragmented cardiac dyads, dilated jSR and reduced jSR contact with T-tubules. Quantitative RT-PCR and immunoblotting analysis revealed altered expression of dyad mRNAs and proteins. Preliminary PLA demonstrated reduced density of LTCC-RyR2 complexes. Furthermore, pressure-induced overload of βII-cKO hearts promoted accelerated heart failure (HF), which can be rescued by treatment with diltiazem. Conclusions: We demonstrate that βII-spectrin is required for cardiac dyad integrity, and that βII-spectrin-mediated HF can be attenuated by diltiazem.